Related Experiment Video
Updated: Oct 15, 2025

A Novel Method for Involving Women of Color at High Risk for Preterm Birth in Research Priority Setting
Published on: January 12, 2018
Racism and pediatric health outcomes
Meghan Fanta1, Deawodi Ladzekpo2, Ndidi Unaka3
1Division of Hospital Medicine, Cincinnati Children's Hospital Medical Center, 3333 Burnet Ave. MLC 5018, Cincinnati, OH 45229, USA.
Insights
Racism significantly harms children's health across multiple levels, leading to disparities in infant mortality, asthma, diabetes, mental health, and surgical care. Addressing racism requires comprehensive strategies targeting individual, institutional, and structural factors.
Area of Science:
- Pediatric Health
- Social Determinants of Health
- Health Equity
Background:
- Racism is a pervasive system impacting health at intrapersonal, interpersonal, institutional, and structural levels.
- It poses a significant threat to the health and well-being of children and adolescents.
- Racism is a critical social determinant of health with profound pediatric implications.
Purpose of the Study:
- To review the impact of racism on pediatric health outcomes.
- To highlight racism as a social determinant of health in child and adolescent populations.
- To call for urgent action to address racism-driven health inequities in pediatrics.
Main Methods:
- This study is a narrative review.
- It synthesizes existing literature on racism and pediatric health.
- Key examples of health disparities are examined.
Main Results:
- Racism is linked to disparities in infant health (mortality), asthma, Type 1 diabetes, mental health, and pediatric surgical conditions.
- Examples include residential segregation's impact on infant mortality and housing practices on asthma.
- Inequitable care, such as disparities in insulin pump use, mental health pharmacotherapy, and pain management for appendicitis, demonstrates interpersonal racism's effects.
Conclusions:
- Urgent action is needed to eliminate pediatric health inequities caused by racism.
- Strategies must address racism at all levels: individual, institutional, and structural.
- Key interventions include workforce diversity, research, equity improvement efforts, community partnerships, co-design, and policy advocacy.
Abstract:
Racism- a system operating at the intrapersonal, interpersonal, institutional, and structural levels- is a serious threat to the health and wellbeing of children and adolescents. This narrative review highlights racism as a social determinant of health, and describes how racism breeds disparate pediatric health outcomes in infant health, asthma, Type 1 diabetes, mental health, and pediatric surgical conditions. Key examples include the association of residential racial segregation and the alarming infant mortality rate among Black infants as well as the role of redlining and discriminatory housing practices on asthma morbidity among Black children and adolescents. Furthermore, inequitable care practices such as (1) racial and ethnic disparities in insulin pump usage in patients with Type 1 diabetes, (2) lower rates pharmacotherapy initiation in racialized children with mental health disorders, and (3) decreased pain medication management and confirmatory imaging in Black children with acute appendicitis, highlight the role of interpersonal racism in propagating poor health outcomes. An urgent call to action is needed to address pediatric health inequities and ensure all children can live healthy lives. Key strategies must tackle racism at the individual, institutional, and structural levels and include building a diverse workforce, prioritizing research to describe the impact of racism on pediatric health outcomes, initiating improvement efforts to close equity gaps, building community partnerships, co-designing solutions alongside patients and families, and advocating for policy change to address the social conditions that impact children and adolescents of color.
More Related Videos
Related Concept Videos
Stereotypes, Prejudice, and Discrimination
Pharmacokinetics in Pediatric Patients: Drug Metabolism
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Pharmacokinetics in Pediatric Patients: Drug Distribution
Bias in Epidemiological Studies

